Plasma Therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and then transfusing antibodies into a patient to kickstart the immune system. The immune system produces antibodies to fight infection and sufficient antibodies can help the person recover.
Plasma therapy aims at building a sick person's immunity, wherein, antibodies are transferred from healthy to the sick person. Convalescent plasma is referred to as the liquid part of blood. The therapy involves transferring plasma from blood to fight the disease.





UK scientists awarded £1m to develop smart gel using plasma tech, offering new hope for brain cancer, skin disease and fungal infection treatments.
The key to his transformation has been the strategic use of vitamins and nutrients, particularly protein and Omega-3 fatty acids, which have played a crucial role in restoring his hair.
Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.
